Pharmaceutical

FDA committee proposes overhaul of perioperative lung cancer trials 

The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.

Jul 28, 2024 - 04:00
FDA committee proposes overhaul of perioperative lung cancer trials 
The ODAC highlighted that perioperative trials should separately evaluate the effectiveness of treatments pre- and post-operation.
Read the original article

Tags:

Previous Article

Balancing instability and robustness: new mathematical framework to understand d...

Next Article

EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The CEO of 23andMe says people are willing to share health data — if ‘treated like adults’

STAT+: The CEO of 23andMe says people are willing to sh...

May 3, 2023

STAT+: 3 health policies states are taking on in 2024

STAT+: 3 health policies states are taking on in 2024

Dec 29, 2023

Opinion: Congress must pass the child tax credit deal to support kids’ health

Opinion: Congress must pass the child tax credit deal t...

Jan 26, 2024